929360081000036101: Medicinal product pack reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept\Reference set\Simple type reference set\Medicinal product pack reference set

Status: current, Primitive. Date: 31-Mar 2011. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module

3288201000168119 MPP (medicinal product pack) reference set en Synonym Active Case sensitive Australian Medicines Terminology module

965507131000036117 Medicinal product pack reference set en Synonym Active Case sensitive Australian Medicines Terminology module

965507141000036110 Medicinal product pack reference set (foundation metadata concept) en Fully specified name Active Case sensitive Australian Medicines Terminology module

4351131000168114 <p>Terminology to describe in a health record an abstract concept representing the properties of one or more quantitatively and clinically equivalent Trade Product Packs.</p><p>This reference set supports the accurate and unambiguous electronic communication and exchange of medicines information between clinicians for medication management and the recording of adverse reactions.</p><p><b>Target client: </b>NCTS</p> en Definition Active Case sensitive Australian Medicines Terminology module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Medicinal product pack reference set	Has licence	SNOMED CT-AU licence	true	Inferred relationship	Some	1740441059
Medicinal product pack reference set	Developed by	Australian Digital Health Agency	true	Inferred relationship	Some	991480534
Medicinal product pack reference set	Is a	Simple type reference set	true	Inferred relationship	Some

Members

tretinoin 0.05% cream, 6 g

triamcinolone acetonide 0.1% paste, 5 g

triamcinolone acetonide 10 mg/mL injection, 5 x 1 mL ampoules

triamcinolone acetonide 0.02% cream, 100 g

triamcinolone acetonide 0.02% cream, 2 g

triamcinolone acetonide 0.02% ointment, 100 g

triamcinolone acetonide 0.02% ointment, 2 g

triamcinolone acetonide 40 mg/mL injection, 5 x 1 mL ampoules

triamcinolone acetonide 55 microgram/actuation nasal spray, 120 actuations

triazolam 125 microgram tablet, 10

triazolam 125 microgram tablet, 50

triclosan 1% soap bar, 100 g

triclosan 1% lotion, 185 mL

triclosan 1% lotion, 200 mL

triclosan 1% lotion, 500 mL

triclosan 1% solution, 1.5 L

triclosan 1% solution, 125 mL

triclosan 1% solution, 5 L

triclosan 1% solution, 500 mL

triclosan 0.3% w/w solution, 1 L

triclosan 0.3% w/v solution, 250 mL

triclosan 0.3% w/v solution, 500 mL

triclosan 1% solution, 40 mL tube

triclosan 1% solution, 20 x 40 mL tubes

triclosan 0.5% gel, 200 mL

trientine dihydrochloride 250 mg capsule, 100

trifarotene 0.005% cream, 15 g

trifarotene 0.005% cream, 30 g

trifarotene 0.005% cream, 5 g

trifarotene 0.005% cream, 75 g

trifluoperazine 1 mg/mL oral liquid, 1 L

trifluoperazine 1 mg tablet, 100

trifluoperazine 15 mg modified release capsule, 50

trifluoperazine 2 mg tablet, 100

trifluoperazine 5 mg tablet, 100

triglycerides long chain with glucose polymer oral liquid, 18 x 250 mL cartons

triglycerides long chain with glucose polymer oral liquid, 27 x 200 mL cartons

triglycerides long chain with glucose polymer oral liquid, 6 x 1 L cartons

triglycerides medium chain and long chain with glucose polymer powder for oral liquid, 400 g

triglycerides medium chain formula powder for oral liquid, 25 x 16 g sachets

triglycerides medium chain formula powder for oral liquid, 30 x 16 g sachets

triglycerides medium chain formula powder for oral liquid, 420 g

trihexyphenidyl (benzhexol) hydrochloride 2 mg tablet, 100

trihexyphenidyl hydrochloride 2 mg tablet, 200 tablets (medicinal product pack)

trihexyphenidyl (benzhexol) hydrochloride 5 mg tablet, 200

trimethoprim 300 mg tablet, 7

trimipramine maleate 25 mg tablet, 50

trimipramine maleate 50 mg capsule, 50

triptorelin acetate 100 microgram / 1 mL injection, 28 x 1 mL syringes (medicinal product pack)

triptorelin acetate 100 microgram/mL injection, 7 x 1 mL syringes

trolamine salicylate 10% cream, 10 g

trolamine salicylate 10% cream, 100 g

trolamine salicylate 10% cream, 125 g

trolamine salicylate 10% cream, 150 g

trolamine salicylate 10% cream, 20 g

trolamine salicylate 10% cream, 250 g

trolamine salicylate 10% cream, 50 g

trolamine salicylate 10% cream, 75 g

trolamine salicylate 12% gel, 5 g sachet

trometamol 18 g (150 mEq)/500 mL injection, 500 mL bottle

tropicamide 1% eye drops, 15 mL

tropicamide 0.5% eye drops, 20 x 0.5 mL unit doses

tropicamide 1% eye drops, 20 x 0.5 mL unit doses

tropicamide 0.5% eye drops, 15 mL

tropisetron 2 mg/2 mL injection, 2 mL ampoule

tropisetron 2 mg/2 mL injection, 10 x 2 mL ampoules

tropisetron 2 mg/2 mL injection, 5 x 2 mL ampoules

tropisetron 5 mg/5 mL injection, 5 mL ampoule

tropisetron 5 mg/5 mL injection, 10 x 5 mL ampoules

tropisetron 5 mg capsule, 2

tropisetron 5 mg capsule, 5

tuberculin PPD (Mantoux) acellular intradermal skin test 50 tuberculin units/mL injection, 1 mL vial

tucatinib 150 mg tablet, 84

tucatinib 50 mg tablet, 88

tyrosine 1 g tablet, 60

tyrosine with carbohydrate containing 1 g tyrosine powder for oral liquid, 30 x 4 g sachets

ubidecarenone 100 mg capsule, 30

ubidecarenone 150 mg capsule, 100

ubidecarenone 150 mg capsule, 125

ubidecarenone 150 mg capsule, 180 capsules (medicinal product pack)

ubidecarenone 150 mg capsule, 30

ubidecarenone 150 mg capsule, 50

ubidecarenone 150 mg capsule, 60

ubidecarenone 150 mg tablet, 30

ubidecarenone 150 mg tablet, 60

ubidecarenone 50 mg capsule, 200

ubidecarenone 75 mg capsule, 30

ubidecarenone 75 mg capsule, 60

ubidecarenone 75 mg capsule, 90

ulipristal acetate 30 mg tablet, 1

ulipristal acetate 5 mg tablet, 28

ulipristal acetate 5 mg tablet, 84

umeclidinium 62.5 microgram / 1 actuation + vilanterol 25 microgram / 1 actuation powder for inhalation, 30 actuations (medicinal product pack)

umeclidinium 62.5 microgram/actuation + vilanterol 25 microgram/actuation powder for inhalation, 7 actuations

umeclidinium 62.5 microgram powder for inhalation, 30 actuations

umeclidinium 62.5 microgram powder for inhalation, 7 actuations

upadacitinib 15 mg modified release tablet, 28

upadacitinib 15 mg modified release tablet, 7

upadacitinib 30 mg modified release tablet, 28

upadacitinib 30 mg modified release tablet, 7

upadacitinib 45 mg modified release tablet, 28

Start Previous Page 155 of 160 Next End

Reference Sets

Reference set descriptor